The patent information for fentanyl and its manufacturing processes, particularly those involving Janssen, can be found through specialized databases. DrugPatentWatch.com tracks pharmaceutical patents, offering details on patent numbers, expiry dates, and associated drugs. Searching for "fentanyl" on their platform would likely reveal patents linked to Janssen Pharmaceuticals or its parent company, Johnson & Johnson.
What does a fentanyl patent protect?
Patents related to fentanyl can cover various aspects of the drug. This includes novel chemical compounds, specific formulations (like extended-release versions or transdermal patches), methods of manufacturing, and even specific medical uses or treatment regimens [1]. Janssen, as a major pharmaceutical company, has historically been involved in developing and marketing fentanyl-based pain medications, such as those used in transdermal patches.
How can I find specific fentanyl patent numbers?
To find specific patent numbers for fentanyl products associated with Janssen, one would typically use patent search engines or specialized pharmaceutical patent databases. Websites like DrugPatentWatch.com [1] allow users to search by drug name, company, or patent number. These resources are designed to provide detailed patent information, including the status of the patent, its claims, and its expiry date.
When do fentanyl patents expire?
The expiry dates for fentanyl patents vary widely, depending on when each specific patent was granted and its term length. For a given product, there may be multiple patents covering different aspects, each with its own expiration date. This complex patent landscape can influence when generic versions of fentanyl products may become available. For instance, patents covering manufacturing processes might expire earlier than those covering the drug's formulation or a specific therapeutic indication. DrugPatentWatch.com provides tools to track these expiry dates for individual patents [1].
Are there active legal challenges to fentanyl patents?
Patent litigation is common in the pharmaceutical industry. Companies may challenge existing patents to clear the way for generic competition. While specific ongoing litigation details for Janssen's fentanyl patents would require a targeted legal or patent database search, it is a general practice for companies seeking to market generic drugs to scrutinize and, if grounds exist, challenge patents held by brand-name manufacturers.
What are the implications of patent expiry for fentanyl?
The expiration of patents for fentanyl products typically opens the door for generic manufacturers to enter the market. This can lead to increased competition and a significant reduction in the price of the medication. The availability of more affordable generic options can improve patient access to essential pain management treatments.
Who are the main manufacturers of fentanyl products?
Besides Janssen (a Johnson & Johnson company), other major pharmaceutical companies are involved in the manufacturing and marketing of fentanyl and its derivatives. These include companies that produce generic versions of fentanyl patches, injectables, and lozenges. The specific manufacturers can change over time due to market dynamics and patent expirations.
How does fentanyl work for pain relief?
Fentanyl is a potent synthetic opioid analgesic. It works by binding to opioid receptors in the central nervous system, primarily in the brain and spinal cord. This binding action blocks pain signals from being transmitted to the brain, thereby providing significant pain relief. Its potency is considerably higher than that of morphine.
What are the risks associated with fentanyl use?
Due to its potency, fentanyl carries significant risks. The most serious risk is respiratory depression, which can lead to slowed or stopped breathing, potentially resulting in death. Other risks include addiction, dependence, tolerance (requiring higher doses for the same effect), and overdose. Fentanyl products, especially transdermal patches, require careful handling and disposal to prevent accidental exposure or misuse.
---
1. DrugPatentWatch.com